The investment bank upgraded the Ohio-based lawn care company to buy from hold.
JPMorgan upgrades this under-the-radar insurance stock, sees it as defensive play in economic slowdown
The firm raised its rating to overweight from neutral.
The sell-off in this cloud stock is overdone and investors should scoop up shares, KBW says
The firm called the stock’s postearnings drop in premarket trading “overdone.”
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 and Nasdaq Composite closed higher on Tuesday as traders awaited Trump’s tariffs. Here’s what’s on CNBC’s radar going into Wednesday.
Where investors can find opportunity in the wake of Trump’s new tariffs on Wednesday, according to EMJ’s Eric Jackson
President Donald Trump’s promise to lift tariffs on Wednesday may provide a compelling entry point for investors in some stocks, according to one money manager.
Here’s why buying Alibaba is a ‘great way to avoid the tariff tantrum,’ says one investor
Investors should lean into Alibaba and Snowflake if they’re looking for stocks to weather tariff risks, said investor Quint Tatro.
Stocks that can best manage the tariff threat, according to Morgan Stanley
The bank screened for companies that have mechanism for handling levies.
Protect your portfolio from a stagflation scenario with these dividend stocks, Jefferies says
Some dividend-paying stocks are poised to hold up in an environment when economic growth is slowing and inflation remains high, the investment bank found.
Investors hope April 2 could bring some tariff clarity and relief. That may not happen
Stocks have been in turmoil, as investors struggle to price in the breadth of President Donald Trump’s policies that are shifting the lines of global trade.
Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ‘underappreciated.’